Skip to content
★ Sign in to follow
HS

HC Surgical Specialists Limited Stock: price and insider trades · Singapore

ISIN SG1DC2000004SG·Mcap SGD 54.4MHealth Care

No insider purchase over the last 90 days. The latest, by Chong Weng Hoe, was filed 21 Jan 2019.

HC Surgical Specialists Limited: what insiders have been doing

HC Surgical Specialists Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SGX. The past year has been quiet: not a single insider filing for HC Surgical Specialists Limited. The previous disclosure was published on 22 September 2023.

Over the whole record (from 2017), the tally stands at 3 purchases and no sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Source: insider filings from SGX. Past trades are no guide to future returns.

Insider Decl.
7
Thresholds
n/a
Buy Volume
€82,295
3 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

  • Filed 21 Jan 2019 · 2848 days ago · €6,781
    -18.3%
    Entry SGD 0.63 · Close at T+365 SGD 0.51
  • Filed 13 Feb 2017 · 3555 days ago · €12k
    +21.4%
    Entry SGD 0.56 · Close at T+365 SGD 0.68

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 115 of 26,911 companies
90.5
score / 100
Value
88
Quality
93
FCF yld12%
Earn yld15%
EV/EBITDA5.3x
ROE35%
Gross mgn84%
Net mgn44%
Debt/EBITDA0.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended May 2026 · cache

SGD 0.36
Analyst consensus
·
Income statement
RevenueSGD 19.1M
Gross profitSGD 16.1M84% margin
EBITDASGD 10.9M57% margin
Net incomeSGD 8.4M35.3% margin
Valuation
PER (trailing)8.9x
P/Book2.6x
Beta-0.16
Balance sheet & cash
Market capSGD 54.4M
Total debtSGD 2.8M
Free Cash FlowSGD 6.7M
Debt / Equity13%
Profitability & ownership
ROE34.8%
ROA10.4%
% insiders81.8%
% institutions1.0%
Last declaration on 22 September 2023
Declarations7 total
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1DC2000004SGX:V35XBME3TOKFOZZP
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SG1DC2000004SGX:6BJAFD4TQF4V52J4
  • ●
    Director/CEOExecutives
    0SGX
    ShareSGX-STISIN SG1DC2000004SGX:1JP02U0E2S5M3SC0
  • ●
    Director/CEOExecutives
    0SGX
    ShareSGX-STISIN SG1DC2000004SGX:5XW1HCXHGWPCFE4F
  • ▲
    Director/CEOExecutives
    10,472 SGD23SGX
    17,600 shares@ SGD 0.5959.6% of flowShareSGX-STISIN SG1DC2000004SGX:RKOCNNQB8K3SD0K4
    Canonical exit: 18 Apr 2019 (T+90)
  • ▲
    Director/CEOExecutives
    102,000 SGD30SGX
    150,000 shares@ SGD 0.6890.4% of flowShareSGX-STISIN SG1DC2000004SGX:PG8VMN344XBAL7VV
    Canonical exit: 21 Jan 2018 (T+90)
  • ▲
    Director/CEOExecutives
    17,850 SGD30SGX
    30,000 shares@ SGD 0.595100.0% of flowShareSGX-STISIN SG1DC2000004SGX:82QWR96YYQXAFP10
    Canonical exit: 11 May 2017 (T+90)

7 of 7 declarations

About HC Surgical Specialists Limited

HC Surgical Specialists Limited is a company focused on surgical solutions, providing innovative services in the healthcare sector. It is listed on the Singapore Exchange.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations